Evaluation of the profile of drug therapy administered through enteral feeding tube in a general hospital in Rio de Janeiro by Silva, Mario Jorge Sobreira da et al.
*Correspondence: M. Sobreira. Av. Maracanã, 450 - Apto. 105 - Maracanã, 




leBrazilian Journal of 
Pharmaceutical Sciences
vol. 47, n. 2, apr./jun., 2011
Evaluation of the profile of drug therapy administered through 
enteral feeding tube in a general hospital in Rio de Janeiro
Mario Jorge Sobreira da Silva1*, Carlos Eduardo Meireles Cava2, Patrícia Kaiser Pedroso2, 
Débora Omena Futuro3
1Pharmacy Service, Hospital of the Servers of the State and Pharmacy Course, Health Sciences School, UNIGRANRIO, 
2Hospital Pharmacy, Faculty of Pharmacy, Federal Fluminense University, 3Pharmaceutical Technology Department, Faculty 
of Pharmacy, Federal Fluminense University
Enteral nutrition (EN) is the method of choice for patients that cannot adequately receive oral feeding 
despite good gastrointestinal tract condition. Enteral diets may be administered through tube or ostomy 
placed in the stomach, duodenum or jejunum. The administration of drugs via enteral feeding tube 
(EFT) is a common practice in hospitals due to patient clinical status, and requires special attention 
from professionals involved in this process. This study entailed an analysis of the profile of drug therapy 
through EFT based on evaluation of medical prescriptions of the Medical Clinic of the Hospital dos 
Servidores do Estado (HSE) of Rio de Janeiro sent to the Pharmacy Service between January and June 
2007, according to standard protocols in place. Prescription of drugs via EFT outside recommended 
guidelines was observed, besides potential drug-nutrient incompatibilities associated with this practice. 
These results point to the need for improvement of enteral route access and the adoption of measures to 
promote safe and effective use of drugs and nutritional therapy.
Uniterms: Enteral nutrition. Drugs/prescriptions. Hospital pharmacy. Pharmaceutical care.
A nutrição enteral (NE) é o método de escolha para alimentar pacientes que não podem receber 
alimentação por via oral de forma adequada, mas que estejam com a função gastrointestinal satisfatória 
para a absorção dos nutrientes. As dietas enterais podem ser administradas através de cateteres ou 
ostomias, posicionados no estômago, duodeno ou jejuno. A administração de medicamentos através de 
cateter de nutrição enteral (CNE) é uma prática muito comum no ambiente hospitalar, devido ao estado 
clínico do paciente, necessitando atenção especial dos profissionais envolvidos neste processo. O estudo 
constituiu uma análise do perfil da terapia medicamentosa através de CNE por meio de uma avaliação 
das prescrições médicas da Clínica Médica do Hospital dos Servidores do Estado (HSE) do Rio de 
Janeiro encaminhadas ao Serviço de Farmácia, de janeiro a junho de 2007, tendo como padrão protocolos 
existentes. Foi observada a prescrição de medicamentos através do CNE fora das recomendações contidas 
nas referências, além de possíveis incompatibilidades fármaco-nutriente associadas a esta prática. Os 
resultados demonstraram a necessidade de melhoria na utilização dessa via e adoção de medidas a fim 
de promover um uso seguro e eficaz de medicamentos e da terapia nutricional.
Unitermos: Nutrição enteral. Medicamentos/prescrição. Farmácia hospitalar. Assistência farmacêutica.
INTRODUCTION
Enteral nutrition (EN) is indicated for patients who, 
for some reason, are unable to ingest food orally despite 
their digestive system functioning both anatomically 
and physiologically (SENPE, 1998). The access routes 
to the digestive tube for insertion of the enteral feeding 
tube (EFT) may vary according to gastrointestinal tract 
pathology and general patient clinical status. The most 
used access approaches are nasoenteral route, gastrostomy 
and jejunostomy. EN may be administered through EFT 
by intermittent or continuous forms (Waitzberg et al., 
2000).
High number of patient candidates to receive EN 
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need treatment with one or more drugs that may also be 
administered through the EFT (Beckwith et al., 2004). The 
use of an inappropriate method of drug administration via 
this route can lead to failures both to medication and nu-
tritional therapy (Gámez Lechuga et al., 1998). Problems 
related to administration of drugs via EFT may result from 
a series of incompatibilities such as physical, pharmaceu-
tical, physiological, pharmacological and pharmacokinetic 
(Izco et al., 2001).
Physical incompatibility happpens when physical 
change occur after mixing the EN and the drug. This may 
lead to formation of precipitates or to viscosity changes 
hinding nutrient or drug absorption due to catheter obs-
truction (Izco et al., 2001). Furthermore, the grinding of 
solid oral medications or the administration of drugs with 
extreme pH values may cause mechanical problems as 
well as catheter obstruction (García de Tiedra, Alonso 
Herreros, 2004; Gámez Lechuga et al., 1998).
When the manipulation of pharmaceutical forms 
modifies the efficacy of the product and its tolerance by 
the patient it constitutes a pharmaceutical incompatibility. 
Also, some pharmaceutical forms, such as enteric coated 
tablets or controlled release tablets need special care when 
administered via catheters (Izco et al., 2001).
The decreased tolerance to nutritional support due 
to pharmacological action of the active principle or to any 
component of the formulation characterizes physiological 
incompatibility (Izco et al., 2001).
Pharmacological incompatibility occurs when the 
drug mechanism of action causes changes in EN tolerance 
or in the efficacy of other administered drugs (Izco et al., 
2001).
Pharmacokinetic incompatibility occurs when the 
drug given via EFT causes changes in its pharmacokinetic 
properties such as bioavailability, distribution, metabolism 
and / or excretion (Izco et al., 2001).
 It is therefore essential to perform proper selection 
and administration of the drug via this route to avoid the 
complications described, with the aim of ensuring the 
effectiveness of the drug and nutritional therapy in patients 
(Gámez Lechuga et al., 1998).
Numerous studies provide specific information and 
key recommendations for the correct administration of dru-
gs via EFT. These works provide data on the peculiarities 
of the drugs that can be administered via this route and the 
alternatives to these drugs that should not be used.
The presence of a Multidisciplinary Team for Nu-
tritional Therapy (MTNT) in hospitals can prevent and 
reduce complications and costs involved in this process, 
and ensure safety and efficacy in the treatment of patients 
(RDC nº 63, 06/07/00) (Brasil, 2000; Moura, Reyes, 
2002). The incorporation of a pharmacist in the MTNT is 
of fundamental importance to prevent problems related to 
administration of drugs via EFT. This professional plays an 
important role in correct selection and provision of infor-
mation on drugs to be administered by this route, as well 
as in solving problems related to it (RDC nº 63, 06/07/00) 
(Brasil, 2000; Gago Sánchez et al., 2006).
The aim of this study was to analyze the profile of 
the drug therapy administered through enteral feeding 
tube at the Medical Clinic of the Hospital dos Servidores 
do Estado (HSE) of Rio de Janeiro and to put forward 
proposals to improve care to patients with EFT.
MATERIAL AND METHODS
A retrospective study of medical prescriptions from 
the Medical Clinic of HSE sent to the Pharmacy Service 
between January and June 2007 was performed. Initially, 
the analysis was estimated for a period of one year but 
most data were not available for this period. The medical 
prescriptions sent to the Pharmacy Service were counted 
and those in which enteral nutrition (EN) via catheter was 
employed, were selected.
From the selected prescriptions, data was collected 
on the date of prescription, the distal placement of the EFT, 
the drugs prescribed via the EFT and the pharmaceutical 
form of each drug.
The dosage available for each drug in the Pharmacy 
Service during the study period was also considered. This 
information was available on AutoEst®, an automated 
system (version 5.7).
The data were compiled into Microsoft EXCEL® 
spread sheet structured for this purpose. The information 
was processed to create secondary spread sheets in the 
same software to determine the profile of drug therapy via 
EFT using the following data: (1) total number of pres-
criptions for patients using EN; (2) number of patients 
in use of EN; (3) number of patients using drugs through 
EFT; (4) total number of prescriptions for patients using 
drugs via EFT; (5) time in use of EFT of patients during 
analysis; (6) distal placement of catheter in patients 
using EN; (7) average number of drugs per prescription 
to be administered by EFT; (8) drugs prescribed by ca-
theter; (9) percentage of pharmaceutical forms of drugs 
prescribed by catheter, grouped by same active princi-
ple and pharmaceutical form, not taking into account 
their concentration; (10) total number of items found in 
prescriptions for drug administration via EFT; (11) fre-
quency of drug items prescribed for administration via 
catheter.
The drugs prescribed via EFT were grouped accor-
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ding to their pharmacological group in the National List 
of Essential Drugs 2007 (Brasil, 2007), taking into consi-
deration the same active principle and form, regardless of 
their concentration in the formulation.
A survey of drugs available in the institution in oral 
liquid form was conducted. This information identified the 
unfamiliarity of standardization of pharmaceutical forms 
of drugs available in the hospital among prescribers, as 
well as lack of awareness of professionals regarding the 
risks of modifying oral solid pharmaceutical forms.
After obtaining the relationship between drugs 
prescribed to patients by EFT, reference recommendations 
available on the use of these drugs through oral route 
were consulted. Careful evaluations of the use of drugs 
on analyzed prescriptions were performed according to 
the guidelines observed.
RESULTS
The Pharmacy Service of the HSE received 9975 
prescriptions from the Medical Clinic between January 
and June, 2007. A total of 330 prescriptions were selected 
of 29 patients in use of EFT. The analysis of prescriptions 
showed that 26 (89.6%) patients received medication via 
catheter, representing 319 prescriptions.
During the analysis period, 21 patients remained in 
use of EFT for up to 30 days, 5 patients for up to 60 days 
and 3 patients for a period greater than or equal to 90 days, 
at the Medical Clinic.
Among 29 patients studied at this period, 16 patients 
(55.1%) had distal post-pyloric EFT placement and 13 
patients (44.9%) had distal stomach EFT placement.
Patients using drugs via EFT were found to be re-
ceiving an average of 4.1 drugs per prescription through 
this route.
Some drugs were prescribed in different doses and 
pharmaceutical forms. Figure 1 shows the distribution 
of pharmaceutical forms of drugs prescribed during the 
analyzed period.
On prescriptions of patients in use of drugs via 
EFT, 1,327 medicines were administered by this route. 
These drugs were grouped by pharmaceutical form, with 
captopril being the most prescribed, as shown in Table I.
The largest group of drugs prescribed to be admi-
nistered through via catheter were the anti hypertensive 
agents (30.9%), followed by anticonvulsants (10.0%) 
and anti-ulcer drugs (7.0%) (Figure 2). For this analysis, 
the antibacterial drugs, antifungal and the antiparasitic 
were considered Anti-Infective Agents, according to the 
classification of the National Essential Drugs List, 2007 
(Brasil, 2007).
FIGURE 1 - Percentage of pharmaceutical forms of medicines 
prescribed by enteral feeding tubes between January and 
June, 2007 among the 26 patients analyzed at the Hospital dos 
Servidores do Estado in Rio de Janeiro.
Among 49 drugs prescribed in solid oral pharmaceu-
tical forms, 17 (34.7%) were also available on oral liquid 
form, implying that at least 290 prescriptions (21.8%) 
could have reduced the risk of catheter obstruction. 
The care taken in administration by EFT of the 56 
drugs prescribed to the 26 patients was investigated based 
on the references used (Hidalgo et al., 1995; Gámez Le-
chuga et al., 1998; Izco et al., 2001; Beckwith et al., 2004; 
Garcia di Tiedra, Alonso Herreros, 2004; Alonso Herreros 
et al., 2004; Piñeiro Corrales, Olivera Fernández, Guindel 
Jiménez, 2006).
Analysis of prescription drugs regarding the distal 
placement of the EFT showed the prescription for one 
patient of haloperidol solution and one patient of N-ace-
tylcysteine powder with post-pyloric placement outside 
the guidelines found in the references consulted.
The same analysis was done on the administration of 
medicines by EFT with regard to the pharmaceutical forms 
available. Three patients were found using the nifedipine 
retard coated tablet, in disagreement with the reference 
recommendations (Hidalgo et al., 1995; Izco et al., 2001; 
López et al., 2003; Beckwith et al., 2004)
DISCUSSION
The use of medicines via EFT is commonly perfor-
med and of great relevance in clinical practice. The use 
of drugs by oral route is chosen due to its lower costs and 
iatrogenic effects (Gámez Lechuga et al., 1998), since it 
is more physiological and has fewer complications than 
the parenteral route (Izco et al., 2001).
In this study, a large number of prescriptions of 
drugs in their pharmaceutical solid oral form was noticed 
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when equivalent liquid formulations were available. This 
suggests a possible lack of dosage forms of medicines 
available in the hospital to the prescribers, and also limited 
knowledge of professionals about the risks of the practice 
of modifying solid oral forms.
On the other hand, liquid formulations have pro-
blems and limitations inherent to their use related to the 
viscosity, osmolarity and the amount of sorbitol present 
in these formulations (Beckwith et al., 2004).
The administration of some oral liquids with high 
viscosity through the catheter could be hard or induce 
catheter obstruction, as occurs with the suspension of 
amoxicillin + clavulanate. These medications should be 
diluted in water to improve administration and prevent 
obstruction of the catheter (Gámez Lechuga et al., 1998; 
Garcia di Tiedra, Alonso Herreros, 2004).
TABLE I - Frequency of medications prescribed for administration through enteral feeding tubes among the 26 patients assessed 





N % N %
Captopril Tablet 222 16.73 Levothyroxine Tablet 15 1.13
Phenytoin Tablet 90 6.78 Simvastatin Tablet 14 1.06
Ranitidine* Tablet 81 6.10 Spironolactone Tablet 13 0.98
Bromopride* Capsule 76 5.73 Amlodipine Tablet 12 0.90
Baclofen Tablet 68 5.12 Omeprazole Capsule 12 0.90
Potassium chloride 6% Solution 49 3.69 Nortriptyline Capsule 11 0.83
Ciprofloxacin Tablet 47 3.54 Hydralazine Dragee 11 0.83
Hydrochlorothiazide Tablet 45 3.39 Digoxin* Tablet 11 0.83
Atenolol Tablet 39 2.94 Dipirone* Tablet 8 0.60




Fluoxetine* Capsule 30 2.26 Thiabendazole* Capsule 7 0.53
Retard Nifedipine Coated tablet 30 2.26 Metoclopramide* Tablet 7 0.53
Folic acid Tablet 28 2.11 Vitamin B1 Tablet 7 0.53
Haloperidol Solution 28 2.11 Tramadol Capsule 6 0.45




Sertraline Tablet 26 1.96 Alopurinol Tablet 6 0.45
Prednisone Tablet 25 1.88 Lactulose Solution 5 0.38
Diazepam Tablet 24 1.81 Bromazepam Tablet 4 0.30
Dipirone Solution 23 1.73 Fluconazole Capsule 4 0.30
Risperidone Tablet 20 1.51 Morphine Tablet 3 0.23
Mineral Oil Solution 20 1.51 Clonazepam* Tablet 1 0.08
Carvedilol Tablet 19 1.43 Ferrous sulfate* Coated tablet 1 0.08
Furosemide Tablet 19 1.43 Dexchlorpheniramine* Tablet 1 0.08
Metformin Tablet 19 1.43 Albendazole* Coated tablet 1 0.08
Phenobarbital* Tablet 17 1.28 Metronidazole* Tablet 1 0.08
Paracetamol Solution 15 1.13 Norfloxacin Tablet 1 0.08




Amoxicilin + Clavulanate* Tablet 15 1.13 Vitamin B* Coated tablet 1 0.08
PF: Pharmaceutical Form
*: Liquid oral pharmaceutical form available in the Pharmacy Service of the HSE
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Other problem related to the administration of liquid 
forms through the EFT include high osmolarity which can 
cause gastrointestinal problems such as diarrhea, abdo-
minal distension and vomiting. For instance, this can be 
observed upon administration of lactulose and the chloride 
potassium solutions of potassium chloride at 6%. Dilution 
before administration is a way of reducing these effects 
(Beckwith et al., 2004).
The sorbitol present in liquid formulations is a fre-
quent cause of abdominal distension and aerophagia with 
daily dose of 10 g, while abdominal spasms and diarrhea 
can occur at a daily dose of 20 g. The recommended 
change is to try the pharmaceutical form or to use alterna-
tive therapy available. The solution of paracetamol is an 
example of a product with a high amount of sorbitol in its 
formulation that was found in the prescriptions analyzed 
(Gámez Lechuga et al., 1998; Beckwith et al., 2004).
Among the oral pharmaceutical forms prescribed 
via EFT, solid forms were more commonly used. When 
prescribing medications in the form of tablets to patients 
using EFT, grinding and mixing in water is suggested to 
administer it as a suspension. The opening of capsules and 
preparing them as in the previous case is recommended. 
However, the suspensions prepared in this manner may 
be related with the obstruction of the EFT, representing a 
critical point of the process. An alternative to avoid this 
problem is the use of liquid formulations when they are 
available or parenteral preparations that can be adminis-
tered orally, such as the tramadol (Hidalgo et al., 1995; 
Garcia di Tiedra, Alonso Herreros, 2004).
Moreover, the reduction of the pharmacological 
effect is observed through the grinding of pharmaceutical 
forms of enteric coated tablets due to the action of the 
gastric pH when the distal positioning of the catheter is in 
the stomach (Garcia di Tiedra, Alonso Herreros, 2004). In 
the analysis, two patients using omeprazole with gastric 
catheter were found. In this case, the correct procedure 
is to open the capsule and release the contents into a 5% 
glucose solution or in fruit juice with no grinding (Izco et 
al., 2001). Three patients using retard nifedipine were also 
found. The oral drugs in retard or controlled-release forms 
are contraindicated for open grinding or for administra-
FIGURE 2 - Pharmacological group of drugs prescribed by enteral feeding tubes between January and June, 2007 among the 26 
patients analyzed at the Hospital dos Servidores in Rio de Janeiro.
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tion via catheter, as they can increase the speed of release 
of the active principle by increasing the absorption and 
plasma to toxic levels or to a lesser degree, lead to loss of 
the maintenance effect of plasma levels with time. In this 
case, liquid dosage forms should be chosen or options that 
do not have controlled-release, adapting for dose and dose 
range. (Hidalgo et al., 1995; Izco et al., 2001; López et 
al., 2003; Beckwith et al., 2004; Garcia di Tiedra, Alonso 
Herreros, 2004).
The administration of drugs with extreme values 
of pH (<3.5 or >10) together with EN may lead to pre-
cipitation of the drug and consequent obstruction of the 
catheter, it being indicated to interrupt EN 1h before, and 
resume it 2h after, drug administration. Also, cases must 
be considered where the distal placement of the catheter is 
post-pyloric and the middle pH is alkaline (duodenum and 
jejunum). In this case it is contraindicated to administer 
dosage forms with acidic pH that may lead to precipitation 
of the drug and consequent therapeutic failure (Gámez 
Lechuga et al., 1998; Izco et al., 2001; Garcia di Tiedra, 
Alonso Herreros, 2004). In the analysis, prescriptions 
drugs were found with pH <3.5, such as metoclopramide 
tablet, fluoxetine capsule, haloperidol solution and n-
acetylcysteine powder. The use of haloperidol solution 
and n-acetylcysteine powder administered through a post-
pyloric catheter was observed in 2 patients.
When drug administration by EFT causes changes 
in pharmacokinetic properties such as bioavailability, dis-
tribution, metabolism and/or excretion or when I produces 
undesirable gastrointestinal effects, the procedure to be 
used is the interruption of nutrition 1h before and 2h after 
the administration of drugs such as atenolol, ciprofloxacin, 
digoxin, phenytoin, levothyroxine and norfloxacin. Ho-
wever, some drugs are more tolerable when administered 
concurrently with NE, such as acetylsalicylic acid, amo-
xicillin + clavulanate, amlodipine, carvedilol, dexchlor-
pheniramine, diazepam, furosemide and spironolactone 
(Izco et al., 2001).
According to the references studied, some oral solid 
medications that are not commercially available in liquid 
formulation, allows preparation through the development 
of an extemporaneous suspension. In these cases, the best 
alternative is the preparation of such formulations by the 
Department of Pharmacy of the institution and sending 
them in a ready form for administration. Among the drugs 
found, folic acid, allopurinol, baclofen, captopril, spirono-
lactone, furosemide, hydrochlorothiazide and prednisone 
could benefit from this preparation (Hidalgo et al., 1995; 
Izco et al., 2001; Piñeiro Corrales, Olivera Fernández, 
Guindel Jiménez, 2006).
FINAL CONSIDERATIONS
The prescription of medicines via EFT is a procedure 
widely used in clinical practice. As can be observed in this 
study, the results showed that it is necessary for the health 
team involved in patient care to pay greater attention to 
ensure this practice is performed safely and effectively.
The administration of medications via catheter re-
quires correct selection of the dosage form and the correct 
form of administration to ensure the effectiveness of phar-
macotherapy, a reduction in adverse effects, prevention of 
catheter obstruction, and avoidance of problems related to 
possible complications that may cause nutritional failure.
The pharmacist, as part of the MTNT, has the res-
ponsibility to improve health through the safe and efficient 
use of medicines. Pharmaceutical intervention can be de-
cisive in the detection and management of possible drug-
nutrient interactions in the prevention and identification of 
problems, by finding practical solutions, especially con-
cerning guidelines for preparation and administration of 
medicines. The development of guides and manuals with 
guidelines for carrying out this practice, disclosure of the 
standard drugs at the institution available to prescribers, 
the inclusion of medicines with liquid formulations in the 
standardization and development of extemporaneous for-
mulations designed for this purpose, also number among 
the actions of the pharmacist.
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